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Abstract
The extracellular matrix (ECM) is a key regulator of tissue morpho-
genesis and repair. However, its composition and architecture are
not well characterized. Here, we monitor remodeling of the extra-
cellular niche in tissue repair in the bleomycin-induced lung injury
mouse model. Mass spectrometry quantified 8,366 proteins from
total tissue and bronchoalveolar lavage fluid (BALF) over the
course of 8 weeks, surveying tissue composition from the onset of
inflammation and fibrosis to its full recovery. Combined analysis
of proteome, secretome, and transcriptome highlighted post-
transcriptional events during tissue fibrogenesis and defined the
composition of airway epithelial lining fluid. To comprehensively
characterize the ECM, we developed a quantitative detergent solu-
bility profiling (QDSP) method, which identified Emilin-2 and colla-
gen-XXVIII as novel constituents of the provisional repair matrix.
QDSP revealed which secreted proteins interact with the ECM, and
showed drastically altered association of morphogens to the insol-
uble matrix upon injury. Thus, our proteomic systems biology study
assigns proteins to tissue compartments and uncovers their
dynamic regulation upon lung injury and repair, potentially
contributing to the development of anti-fibrotic strategies.
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Introduction
The lung is constantly subjected to harmful exposures, such as
inhaled toxic substances, particulate matter, autoimmune reactions,
and viral or bacterial infections that cause injury to the airway and
alveolar epithelium. The epithelial lining of the airway lumen has a
relatively slow turnover in homeostasis. Upon injury, however,
rapid mobilization of several multipotent progenitor cell and stem
cell lineages can regenerate the epithelial barrier (Kumar et al,
2011; Desai et al, 2014; Hogan et al, 2014; Kotton & Morrisey, 2014;
Lee et al, 2014; Vaughan et al, 2015; Zuo et al, 2015). Lung regener-
ation is mediated by the reactivation of developmental programs,
where the crosstalk between mesenchyme and epithelium via
secreted proteins is essential. In a process called fibrogenesis,
several mesenchymal cell populations secrete and assemble a
specialized provisional extracellular matrix (ECM), which acts as a
scaffold and master regulator of developmental programs in concert
with extracellular morphogens, such as growth factors, cytokines,
and chemokines (Gurtner et al, 2008). Morphogens can interact
specifically with ECM proteins and glycosaminoglycans, which alter
biological activity by affecting their signaling capacity (Chen et al,
2010), relative positioning to other receptor ligands (Hynes, 2009),
or tissue residence time and spatial positioning (Weber et al, 2013).
Bioinformatic analysis of protein domain architecture, together with
literature mining, has defined an ECM component list (the “matri-
some”) by classifying secreted proteins into structural constituents
of the ECM (“core matrisome”) and ECM-interacting proteins
(“matrisome-associated”) (Cromar et al, 2012; Naba et al, 2012a,b).
Many of these annotations, however, are not based on direct experi-
mental observations or have not been comprehensively tested
in vivo. Developmental signaling pathways active in tissue repair,
such as the TGF-b, Wnt, Shh, or Bmp pathways, which emanate
from secreted morphogens and are regulated by interacting ECM
components (Kleinman et al, 2003), are often deregulated in chronic
lung diseases, potentially causing persistent pulmonary fibrosis
(Fernandez & Eickelberg, 2012). Bleomycin-induced lung injury,
which induces robust fibrogenesis 2 weeks after injury, is the most
frequently used animal model of pulmonary fibrosis (Mouratis &
Aidinis, 2011; Bauer et al, 2015). In contrast to progressive and
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irreversible fibrosis in many chronic lung diseases, bleomycin-
induced fibrogenesis is a transient physiological reaction that largely
resolves within 4–8 weeks, leading to almost complete regeneration of
functional alveolar organization (Rock et al, 2011; Hecker et al, 2014).
Here, we employed the bleomycin lung injury mouse model and
recent advances in mass spectrometry (MS)-based proteomics to
generate a proteomic systems biology view on tissue injury, fibrosis,
and repair. In particular, a next-generation Quadrupole–Orbitrap
mass spectrometer (Q Exactive) with improvements in scan speed
and sensitivity (Michalski et al, 2011; Altelaar & Heck, 2012; Mann
et al, 2013) was combined with improved chromatography (Kocher
et al, 2011; Thakur et al, 2011), biochemical sample processing
(Kulak et al, 2014), and data analysis software for accurate
intensity-based label-free quantification (Cox et al, 2014). The
development of streamlined proteomic workflows, including a novel
quantitative detergent solubility profiling (QDSP) method, resolved
the pulmonary proteome into the interstitial proteome, its ECM
components, and the epithelial lining fluid proteome of the alveolar
and airway lumen. We directly measured the interactions of morpho-
gens and other secreted proteins with the ECM in an unbiased way,
revealing those that are bound to the matrix, signaling from that
location or awaiting release by specific activating events. The time-
resolved proteomic signatures revealed candidate molecular players
for both the mobilization of multipotent epithelial progenitor cells
early after injury and the resolution of fibrosis later in regeneration.
Results
Quantitative detergent solubility profiling (QDSP) defines
matrisome composition in vivo
Morphogen solubility differences and gradients are critical in devel-
opment and tissue repair (Martino et al, 2014). The ECM is highly
insoluble, which allows its relative enrichment by extraction and
depletion of more soluble proteins (Naba et al, 2012a). Interactions
of secreted proteins with the ECM niche decrease their solubility,
and thus, correlation analysis of the characteristic protein solubility
profiles would enable the assignment of “matrisome association”
in vivo. We therefore developed a protein correlation profiling
method (quantitative detergent solubility profiling, QDSP), in which
we extracted four distinct fractions from total lung tissue homogen-
ates by gradually increasing the stringency of the detergents (see
Materials and Methods), and analyzed the fractions separately by
LC-MS/MS. Using label-free protein quantification in the MaxQuant
software environment (Cox et al, 2014), we compared the relative
abundance of proteins in the four solubility fractions and between
experimental conditions. To increase throughput, we analyzed each
protein solubility fraction with minimal peptide separation into two
fractions. Thus, measurement time was lower than approaches
based on extensive peptide fractionation, while yielding an extra
dimension of spatial information together with a deep total
proteome (Fig 1A).
We quantified 8,366 proteins including 435 matrisome proteins
(171 core matrisome and 264 matrisome-associated) from healthy
mouse lungs (PBS; n = 4) and lungs 14 days after a single intratrac-
heal instillation of bleomycin (Bleo; 3 U/kg; n = 4) (Fig 1B;
Table EV1). We did not observe a strong bias against matrisome
proteins (Naba et al, 2012a) in the proteomic analysis, evidenced by
the only slightly reduced median sequence coverage of core matri-
some proteins compared to all other proteins (Fig 1C). As expected,
most core matrisome proteins were strongly enriched in the deter-
gent-insoluble protein fraction, while putative matrisome-associated
proteins displayed a more heterogeneous enrichment (Fig 1D). Prin-
cipal component analysis (PCA) (Fig 1E) and unsupervised hierar-
chical cluster analysis (Fig EV1A), together with annotation
enrichment of the observed clusters (Fig EV1B; Table EV2), clearly
confirmed the successful quantitative separation of cytosolic,
membrane, nuclear, cytoskeletal, and ECM proteins by their respec-
tive detergent solubility profiles. Examination of the proteins driving
the separation (the “loadings” of the multidimensional PCA)
showed that members of various multiprotein complexes were
consistently grouped together by QDSP. For instance, the cytosolic
20S proteasome complex was most soluble, followed by the
members of the mitochondrial respiratory chain complex, the
nuclear Ikaros complex, and the basement membrane-associated
laminins, which represented the most insoluble complexes (Fig 1F).
Lung injury could change protein abundance or protein localization
or both, and these scenarios can be distinguished by QDSP. We first
determined changes in the total abundance of proteins based on the
summed peptide MS intensity values across the four solubility
fractions. A t-test between total protein abundance of PBS-treated
lungs and lungs 14 days after bleomycin revealed 1,125 signifi-
cantly regulated proteins (FDR < 5%; Table EV1). Next, we
normalized the data to remove differences in total protein
abundance and investigated changes in solubility profiles between
bleomycin-treated lungs and PBS controls. FDR-controlled ANOVA
testing on the normalized solubility profiles identified 283 proteins
with altered QDSP behavior (Fig EV2A; Table EV1). Annotation
term enrichment identified the two ECM categories “basal lamina”
and “fibrinogen complex” with significant changes upon bleomycin
injury (Table EV3). The fibrinogen complex, which is soluble in
blood plasma and insoluble upon blood coagulation, significantly
shifted into the insoluble compartment upon injury (Fig EV2B). In
contrast, the core structural constituents of the basement
membrane (collagen-IV chains, laminins, nidogens, perlecan;
n = 21) became significantly more soluble (Fig EV2C). Matrisome
proteins (Naba et al, 2012a) whose abundance was unchanged but
whose solubility profiles were significantly altered included the
glycoproteins Netrin-1 (Ntn1) (Fig 1G) and Multimerin-2 (Mmrn2)
(Fig 1H), which were less strongly associated with the ECM, and
the proteoglycan Mimecan (Ogn), whose association with the ECM
increased after injury (Fig 1I).
Next, we analyzed putative matrisome-associated proteins by
unsupervised hierarchical clustering (Fig 2), which separated highly
soluble proteins from insoluble proteins, while simultaneously
showing regulation by injury. Notably, the most insoluble cluster
contained important secreted morphogens of the Wnt, Bmp/Tgfb,
and Fgf families, indicating strong interactions of these proteins
with matrisome constituents. Another cluster contained proteins,
including members of the Mmp, S100, and Serpin families, which
were highly upregulated after bleomycin treatment. These proteins
were spread over all four solubility fractions, indicating that they
still partially reside in the endoplasmic reticulum and Golgi
compartments or were just secreted and not yet incorporated into
the ECM. Almost half of the putative matrisome-associated proteins
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Figure 1. Quantitative detergent solubility profiling (QDSP) enables in-depth analysis of matrisome composition.
A Experimental workflow.
B Number of quantified proteins in the indicated protein fractions and experimental conditions. The mean and standard deviation are shown (PBS, n = 4; Bleo d14,
n = 4).
C, D The box and whisker plots depict the distribution of protein sequence coverage (coverage of possible tryptic peptides per protein in %) (C) or the percentage of MS
intensity in the most insoluble protein fraction (D) for the indicated matrisome categories (Naba et al, 2012a) and experimental conditions.
E Principal component analysis (PCA) separates protein fractions derived from sequential detergent extraction. The first two components of data variability of 6,641
proteins, from four replicates of PBS control (open circles) and four replicates of bleomycin-treated lungs at day 14 after injury (closed circles), are shown.
F The scatter plot depicts the protein feature loadings of component 1 and component 2 of the PCA in (E) for the four indicated multiprotein complexes.
G–I Normalized QDSP MS intensity profiles (left panel) and total protein abundance (right panel) are shown for the indicated example proteins Netrin-1 (G),
Multimerin-2 (H), and Mimecan (I). Error bars depict the standard error of the mean, and the indicated P-values are derived from an ANOVA test (all fractions: PBS,
n = 4; Bleo d14, n = 4).
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(Naba et al, 2012a), including many members of the Annexin,
Cathepsin, S100, and Serpin family of proteins, clustered together as
highly soluble proteins, demonstrating that they were not signifi-
cantly bound to the ECM (Fig 2).
Transcriptional and post-transcriptional regulation of
tissue fibrogenesis
To investigate the nature and extent of post-transcriptional events
upon lung injury, we analyzed identical tissue homogenates with
both RNA-seq and mass spectrometry (n = 8; 4 × PBS, 4 × Bleo).
The RNA FPKM values from RNA-seq (Table EV4) could be
matched with protein MS intensities for 6,672 genes (Fig EV3A).
Using a cutoff of FPKM values at 1 (log2), we determined cover-
age of gene categories in the proteome relative to the transcriptome.
Almost all categories, including the matrisome, were equally
covered, demonstrating that the proteomic analysis was largely
unbiased (Fig EV3B). To systematically compare the proteomic
and transcriptomic datasets in terms of gene categories, we used
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Row z-score
Adamts17 C1qtnf5 Htra1 Mmp28 Timp3
Adamts5 C1qtnf7 Htra3 Mmp9 Tnfsf12
Adamtsl1 Chrdl1 Inhbc Pcsk5 Vegfa
Adamtsl3 Clec11a Itih5 Plxdc2 Wnt3a
Adamtsl4 Crlf1 Lgals8 Sema3a Wnt7b
Adamtsl5 Cxcl12 Lgals9 Sema3b
Ambp Egfl7 Lox Sema3c
Angptl2 F13b Loxl1 Sema3e
Tnfsf13 Fgf2 Loxl2 Sema3f
Bmp3 Fgf23 Loxl3 Sema3g
Bmp6 Frem1 Megf6 Tgfb2
C1qtnf1 Frem2 Mmp19 Tgm2
Adamts1 Leprel2 Plod3 Serpinh1
Adamts15 Lgals3 Rptn Sfrp1
Bmp1 Lgals7 S100a14 Sulf1
C1qa Mmp12 S100a16 Tgm1
C1qb Mmp14 S100a4 Tgm3











A2m;Pzp Colec12 Gpc4 S100a10 Serpinb6
Adam10 Cpn2 Hcfc1 S100a11 Serpinb6b
Adam17 Crlf3 Hpx S100a13 Serpinb8
Adam9 Cst3 Hrg S100a6 Serpinb9
Agt Cstb Hyal2 S100a8 Serpinb9b
Anxa1 Ctsa Il16 S100a9 Serpinc1
Anxa11 Ctsb Il1rn S100g Serpinf1
Anxa2 Ctsc Lgals1 Scube1 Serping1
Anxa3 Ctsd Mbl2 Sdc4 Sftpa1
Anxa4 Ctsg Mmp3 Serpina10 Sftpb
Anxa5 Ctsh Mmp8 Serpina1a Sftpc
Anxa6 Ctss Muc1 Serpina1b Sftpd
Anxa6 Ctsz Ngly1 Serpina1c
Anxa7 Cxcl14 P4ha1 Serpina1d
Anxa8 Cxcl15 Pf4 Serpina1e
Anxa9 Elane Plau Serpina3k
Ccl21a F12 Plxna1 Serpina3m
Clec14a Fgf1 Plxnb2 Serpina6
Clec1a Fstl1 Ppbp Serpina7




Figure 2. Assignment of secreted proteins to the extracellular matrix niche in vivo.
Proteins annotated with the term “matrisome-associated” (Naba et al, 2012a) were grouped using unsupervised hierarchical clustering of the z-scored MS intensities across
the indicated experimental groups and protein fractions. Gene names within individual clusters are shown in boxes in the right panel.
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(Cox & Mann, 2012), which detects correlated and uncorrelated
changes between two data dimensions (Fig 3A; Table EV5). For
instance, Cilium proteins were downregulated in both datasets
(Fig 3B), whereas only the proteome data showed highly signifi-
cant upregulation of blood coagulation proteins (Fig 3C) and
downregulation of tight junction proteins (Fig 3D). Interestingly,
the basement membrane proteins were reduced even though their
transcripts were upregulated (Fig 3E). The correlation of RNA
abundance ratios with protein abundance ratios (Bleo/PBS) was
rather moderate (Pearson r = 0.39), indicating post-transcriptional
regulation of many biological processes in lung injury repair.
Plotting individual RNA and protein ratios (Bleo/PBS) revealed
the significant outlier proteins with the highest magnitude changes
on both transcript and protein levels. Interestingly, several matri-
some-associated morphogens and known regulators of lung
morphogenesis (Dean et al, 2005; Vadivel et al, 2013), including
semaphorin-3C (Sema3c), nephronectin (Npnt), and Wnt3a, were
only regulated at the protein level (Fig 3F). Thus, combined
transcriptomic and proteomic analyses uncovered the level of
regulation of proteins and processes important in lung repair,
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Figure 3. Combined proteomic and transcriptomic analyses uncouple transcriptional and post-transcriptional events upon lung injury.
A The bar graph shows the normalized annotation enrichment score (1 min to +1 max) of UniProt keyword annotations that were significantly regulated (FDR
< 1%) in the proteome (blue bars) and/or the transcriptome (red bars) dataset.
B–E The box and whisker plots depict the distribution of median log2 ratios from the transcriptome experiment (red boxes) and the proteome experiment (blue boxes)
for the indicated UniProt keyword gene categories.
F The scatter plot shows the median log2 ratios of MS intensities and FPKM values for individual genes (n = 6,672). Genes that were significantly regulated in both
RNA and protein are highlighted in red (FDR < 5%). Three example proteins that were only significantly regulated in the proteome but not in the transcriptome are
shown in the bar graph inset. Error bars depict the standard error of the mean (PBS, n = 4; Bleo day 14, n = 4).
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Time-resolved analysis of tissue proteome remodeling upon lung
injury and repair
The bleomycin-mediated injury of the alveolar epithelium leads to
an inflammatory response, which leads to maximal fibrogenesis
2 weeks after injury. Subsequently, the provisional ECM gets
remodeled and repair is resolved within 8 weeks after injury
(Bakowska & Adamson, 1998; Hecker et al, 2014). We characterized
the dynamics of tissue repair upon bleomycin treatment using H&E
(Fig EV4A) and collagen type I stainings (Fig EV4B) at different time
points after bleomycin injury and confirmed the almost complete
resolution of tissue repair within 8 weeks post-bleomycin treatment.
To characterize the proteome changes after injury associated with
inflammation (day 3), fibrogenesis (day 14), remodeling (day 28),
and resolution (day 54), we homogenized total lung lobes from
eight mice for each time point after a single intratracheal instillation
of bleomycin (n = 18; Bleo 3 U/kg) or control saline (n = 16; PBS)
(Fig 4A). We quantified 8,019 protein groups with a median number
of 5,020 identified proteins per single replicate sample (n = 34), and
generated abundance ratios (Bleo/PBS) by dividing individual
replicates by the median value of all PBS control samples (n = 16).
In case of only missing intensity values (protein not identified) in
one of the experimental conditions, we used data imputation (see
Materials and Methods) at the low end of the intensity dynamic
range if we obtained at least 50% valid intensity values in the other
condition. In this way, the MS intensities of a total number of 6,236
protein groups (with protein quantification for at least three repli-
cates in one of the experimental conditions) were finally used for
the ratiometric time course analysis (Table EV6). Remarkably, a
total of 3,032 of these proteins, including 154 matrisome compo-
nents, changed significantly in at least one of the time points
(ANOVA; FDR < 5%) (Fig 4A). We assigned biological processes,
and their upstream transcriptional regulators and growth factors to
the consecutive phases of tissue repair (Fig 4B; Table EV7) (see
“Ingenuity pathway analysis” in Materials and Methods). For
instance, abundance changes in 365 known targets of TGF-b
signaling indicated that the activity of this master regulator of tissue
fibrogenesis was highly upregulated at day 14 after injury and that it
was back to baseline at day 28 (Fig 4B). This revealed the temporal
dynamics of transcriptional networks, allowing the identification of
transcriptional regulators with putative novel functions in lung
repair.
Individual differences in severity of bleomycin-induced lung
injury and dynamics of the repair response lead to variations in the
degree of fibrogenesis, which could be correlated with the proteome
of individual mice. We employed a test of lung compliance to
capture the degree of tissue fibrogenesis. In clinical practice,
measurement of pulmonary compliance captures the lung’s ability to
stretch and expand, which is reduced in fibrosis and increased in
lung emphysema. In the bleomycin model, we observed that the
median lung compliance was slightly reduced at day 3 and severely
reduced at day 14 after injury, after which it returned back to the
level of PBS-instilled control mice at days 28 and 56 (Fig EV4C). For
each protein, we determined how their temporal abundance profiles
correlated with lung compliance changes (Table EV6). For instance,
the ECM glycoprotein tenascin-C (Tnc) correlated negatively with
the compliance ratio, meaning that larger amounts of the protein
were associated with stiffer lung tissue. The opposite was the case
for the collagen-IV triple helical subunit Col4a5, a key constituent of
the alveolar basement membrane (Fig 4C; n = 34). We plotted the
correlation fit slope of all quantified proteins against the Pearson r as
a measure of the tightness of the correlation. Those with negative
slope can be associated with a possible function in the inflammatory
and fibrogenic phase and those with a positive slope with the remod-
eling and resolution phase. A total of 507 proteins (54 matrisome
proteins) had a significant correlation with lung compliance
(FDR < 5%) (Fig 4D). A statistical test (1D annotation enrichment)
revealed gene categories that were enriched with negative and posi-
tive slopes, respectively (Table EV8).
Next, we z-scored MS intensity ratios of the 154 matrisome
proteins that were significantly regulated (FDR < 0.05) and grouped
them by correlation using unsupervised hierarchical clustering into
early and late factors in repair (Fig 5A). This analysis revealed inter-
esting heterogeneous regulation of interacting proteins, such as for
instance the laminin heterotrimers of the basement membrane,
which exist in 16 possible combinations and have a tissue- and
developmental stage-specific distribution and differential functions
in lung development and homeostasis (Domogatskaya et al, 2012).
We quantified all existing laminin chains (five a-, three b-, and three
c-chains) and predicted the possible heterotrimer combinations
based on their MS intensity (Fig EV5A). The a3- and a5-laminins
were most abundant in adult mouse lung, followed by a4-laminins.
The a1- and a2-laminins, which are mainly restricted to embryonic
development (Nguyen & Senior, 2006), were at least ten-fold lower
expressed than all other laminins. Upon injury, the high-abundance
laminin chains were downregulated at day 3 and day 14 together
with the collagen type IV chains. In contrast, the laminin a1-, a2-,
and a4-chains were upregulated early upon injury, suggesting a
potential role in initiation of tissue repair. The a1-laminins had their
peak of expression at day 14, while the a2-laminins were upregulated
very early upon bleomycin injury, and peaked already at day 3
(Fig EV5B). We identified a signature of 50 other secreted and
transmembrane proteins with a peak of expression at day 3
(Fig EV5C). Interestingly, this signature also contained the ECM
protein thrombospondin-1 (Thbs1), recently reported to be a key
factor for alveolar differentiation of bronchoalveolar stem cells upon
bleomycin injury (Lee et al, 2014).
The relative proportion of different cell populations after injury is
affected by differential proliferation, immigration, and cell death. To
extract individual cell-type dynamics from the proteomic data, we
employed cell-type-specific gene expression signatures derived from
single-cell RNA-seq profiling of lung-resident epithelial cell types
(Treutlein et al, 2014), or microarray-based profiling of highly puri-
fied leukocyte populations (Gautier et al, 2012; Miller et al, 2012;
Jojic et al, 2013) (Table EV9). This identified ten different cell types,
whose abundance changed significantly during lung injury (Fig 5B).
For instance, the set of 27 proteins quantified from the signature of
alveolar type 1 epithelial cells (AEC-1), indicated that AEC-1 cells
were unchanged at day 3, significantly downregulated at day 14 and
day 28 and recovered at day 56. Overall, one group of cell types,
including granulocytes, myofibroblasts, pericytes, macrophages,
and B cells, were increased in the fibrogenic or remodeling phase.
At the same stage, all major epithelial cell types, including type 1
and type 2 (AEC-1 and AEC-2), ciliated, and Club/Clara cells were
downregulated and, interestingly, recovered with different kinetics
(Fig 5B–K).
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Figure 4. Tissue proteome time course analysis reveals lung injury repair protein signatures.
A Schematic of experimental design and hierarchical clustering analysis of 3,032 MS intensity ratios (Bleo/PBS; log2) that were significant in ANOVA (day 3, n = 3;
day 14, n = 7; day 28, n = 4; day 56, n = 3).
B Hierarchical clustering of the activity score of downstream biological functions (left panel) and the upstream transcriptional regulators and growth factors (right
panel) for the indicated time points after injury as determined by Ingenuity pathway analysis using the 3,032 significant protein ratios.
C Correlation of protein abundance changes with lung compliance changes in individual mouse lungs at the indicated time points after bleomycin instillation into the
airways. The ECM glycoprotein Tnc serves as an example for proteins that have a negative slope of the correlation fit. The basement membrane protein Col4a5 serves
as an example for proteins that have a positive slope of the correlation fit.
D The scatter plot depicts the Pearson correlation coefficient and the correlation fit slope of all 6,236 proteins that were used in the ratiometric analysis of protein
abundance versus lung compliance. The statistical significance of the correlation coefficient is color-coded as indicated.
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Novel ECM proteins upregulated upon lung injury
Among the most highly regulated proteins, we unexpectedly found
the ECM proteins Emilin-2 and collagen-XXVIII, which have never
been described in the context of tissue injury repair or fibrosis. They
showed similar temporal profiles of expression with significant
upregulation already at day 3 and a peak at day 14 (Fig 6A and D).
Both proteins ranked in the lowest abundance quartile of the prote-
ome in steady-state conditions and increased to median abundance
range at day 14 (Fig 6B and E). Furthermore, the QDSP profiles of
both proteins showed that they became more insoluble in the bleo-
mycin-treated lungs, thus confirming their incorporation into the
ECM (Fig 6C and F). We validated these findings using immunofluo-
rescence on tissue sections from PBS- and bleomycin-treated
animals (day 14). Emilin-2 localized to perivascular and peribron-
chiolar regions and was absent from the alveolar regions in the
lungs of healthy control mice (Fig 6G). In the bleomycin-treated
lungs, it also occupied alveolar regions and was localized around
a-SMA-positive myofibroblasts (Fig 6H). Staining Emilin-2 together
with a fibronectin antibody revealed the co-localization of these two
proteins in a fibrillar network around myofibroblasts (Fig 6L).
Collagen-XXVIII localized in thin sheets around vessels, airways,
and alveoli, which were reminiscent of basement membranes in
healthy control mice (Fig 6I). Upon bleomycin injury, we observed
strong staining with a patchy appearance in fibrotic foci that,
however, did not co-localize with a-SMA-positive myofibroblasts
(Fig 6J). Co-immunostaining of Emilin-2 with collagen-XXVIII
confirmed their mutually exclusive localization and suggests that
these ECM proteins are secreted and assembled by distinct cell
lineages even though their temporal expression profile upon injury
is highly similar (Fig 6K). Thus, immunofluorescence-based valida-
tion of novel ECM proteins identified by our proteomic analysis of
lung injury reveals the complexity of the provisional wound ECM
and its spatiotemporal distribution into distinct zones of differential
ECM composition.
In vivo secretome dynamics in tissue repair
The airway lumen is covered by the epithelial lining fluid (ELF) into
which epithelial cells and alveolar macrophages secrete proteins and
peptides with a multitude of functions, including innate immunity,
mucociliary clearance, and antioxidant defense. ELF and non-adherent
cells in the airways can be sampled from lungs using bronchoalveolar
lavage (BAL) (Reynolds, 2011), which is also a frequently used clinical
procedure for diagnosis and monitoring of chronic lung diseases.
We used MS-based secretome analysis (Meissner et al, 2013) to
profile BALF of the mice from which tissue samples were taken and
of additional mice at day 7 and day 21, for a total of six time points
(four mice each for bleomycin treatment and control, n = 48; Fig 7A;
Table EV10). Single-shot LC-MS/MS quantified a remarkable median
of 1,363 proteins per replicate in the PBS control and 823 after bleo-
mycin application (Fig EV6A). Of the more than 2,000 identified
proteins, 356 were previously categorized as “secreted”. Interest-
ingly, 313 proteins were annotated as “transmembrane,” including
aminopeptidase A (ENPEP), aminopeptidase N (ANPEP), CD166
(Alcam), neuropillin-1 (NRP1), and epidermal growth factor receptor
(EGFR), which were highly regulated in BALF (Figs 7B and EV6B).
Proteins identified in BALF with high-sensitivity MS methods could
also originate from tissue leakage or cell lysis artifacts. By quantify-
ing the tissue proteome against the BALF proteome, we constructed
a t-test-based enrichment score, which unequivocally assigned ELF-
specific proteins (Fig 7C). This analysis distinguished obvious
contaminants such as nuclear lamins (Lmnb1), histones (Hist1h3b),
or basement membrane proteins (Hspg2, Nid1), from dedicated ELF
proteins such as the Clara cell secretory protein (Scgb1a1) or the
pulmonary surfactants (Sftpa, Sftpd). In total, we identified 247
proteins significantly enriched in ELF (Fig 7D). Proteins specific for
the non-secretory AEC-1 had significantly lower BALF enrichment
scores than the proteins specific for the secretory AEC-2 and Club/
Clara cells (Fig 7E). Further validating the analysis, proteins anno-
tated with the term “cytoplasm” showed a negative BALF enrich-
ment score, while most “secreted” and many “transmembrane”
proteins had a significant positive score (Fig 7F).
Having determined the composition and origin of proteins in
BALF, we applied ANOVA to the total time course (Table EV10) and
z-scored the 188 significant secreted or transmembrane proteins. The
temporal behaviors of most proteins were either consistent with
a possible function in inflammation or fibrogenesis (cluster A) or
remodeling and resolution (cluster B) (Fig 7G). Representative for
cluster A, the abundance of the glycosylphosphatidylinositol (GPI)-
specific phospholipase D (Gpld1), which is abundant in serum
(LeBoeuf et al, 1998), was drastically increased within the first
2 weeks after injury and thereafter gradually declined back to
baseline, concomitant with repair of the blood barrier in the lung
(Fig 7H). Cluster B is exemplified by the immunomodulatory
secreted protein acidic mammalian chitinase (Chia) (Lee et al,
2011), which was strongly downregulated the first 2 weeks after
injury and recovered thereafter (Fig 7I).
Discussion
We developed advanced proteomics technologies and applied them
to study fibrosis and regeneration in the lung. This shed light on the
interactions of morphogens and other secreted proteins with the
◀ Figure 5. Matrisome dynamics in tissue repair and extraction of individual cell-type dynamics from the proteomic data.A The z-scored MS intensity ratios of the indicated 154 matrisome proteins (ANOVA FDR < 0.05) were grouped by correlation using unsupervised hierarchical
clustering. The table shows the gene names of the proteins associated with the indicated clusters.
B The normalized enrichment score (1 to +1; 1D annotation enrichment in the Perseus software) of the indicated cell-type-specific protein signatures and time
points after injury was grouped based on non-supervised hierarchical clustering. Conditions with significant enrichment or depletion of a cell-type-specific
signature are marked with an asterisk (P-value < 0.05).
C–K The line plots show dynamic changes in relative abundance (log2 ratio bleomycin/PBS) of the indicated examples of cell-type-specific proteins over the tissue repair
progression timeline. The mean and standard error of the mean and a P-value from ANOVA are shown (day 3, n = 3; day 14, n = 7; day 28, n = 4; day 56, n = 3).
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ECM, quantified protein secretion, and receptor shedding into the
airway lumen and uncovered the temporal dynamics of a large frac-
tion of the proteome upon lung injury and repair (summarized in
Fig 8). The proteomic datasets and data plots can be viewed and
mined for analysis via a unified resource at the MaxQB proteomics
database (Schaab et al, 2012), and in the Tables EV1, EV6 and
EV10.
Proteomic studies of the ECM typically analyze the insoluble
material left after application of different decellularization protocols
(Didangelos et al, 2010; Barallobre-Barreiro et al, 2012; Naba et al,
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Figure 6. Validation of novel ECM proteins strongly upregulated upon lung injury.
A–F Quantitative proteome data depict protein abundance changes over time relative to healthy control mice (A, D), the abundance rank relative to all other quantified
proteins (b, e), and the QDSP profiles indicative for the detergent solubility (C, F). The mean and standard error of the mean are shown (day 3, n = 3; day 14, n = 7;
day 28, n = 4; day 56, n = 3).
G–L Lung tissue sections from control mice (PBS) and bleomycin-treated mice 2 weeks after injury (Bleo d14) were stained as indicated. Scale bars are in lm. Vessels
are labeled with (v) and airways with (a).
Molecular Systems Biology 11: 819 | 2015 ª 2015 The Authors














































Secreted & transmembrane proteins
Z-scored median ratios (Bleo/PBS; log2)











Ace Cfd Ephx1 Lpl Scgb1a1
Ace2 Chad Erap1 Lrp1 Serpinb1a
Acsl1 Chi3l1 Fam3c Lyz1 Sftpa1
Agr2 Chi3l3 Fbln1 Lyz2 Sftpb
Alcam Chia Fgfr2 Man2b2 Sftpd
Anpep Clic1 Fmo3 Mcam Slc25a5
Anxa1 Clic5 Gas6 Met Slc39a4
Anxa11 Clic6 Gpr116 Mme Sort1
Anxa2 Creg1 Gprc5a Mrc1 Sparc
Anxa8 Ctsa Gsn Muc4 Spint1
Atp1a1 Ctsc Hdgf Myof Spp1
Atp1b1 Ctsd Hp Napsa Tspan8
Bcam Ctsh Icam1 Npc2 Vdac1
Bpifa1 Ctss Igfals Nrp1 Wfdc2
C5 Ctsz Ighg2c Orm1
Calu Cxcl15 Il6st Pam
Capg Cyb5 Itgb2 Pigr
Cd36 Dpp4 Lamp2 Ppia
Cd44 Efemp1 Lgals3 Prom1
Cdh1 Enpep Lgals3bp Ptprg
A2m C8b Fgb Klkb1 Serpinf2
Adipoq C9 Fgg Kng1 Serping1
Afm Cd5l Fn1 Kng1 Sparcl1
AI182371 Cdh5 Fstl1 Kng2 Tcn2
Ambp Cfh Gc Lbp Thbs1
Apcs Cfi Gm20547 Lcat Tnc
Apoa1 Clec3b Gpld1 Masp2 Vtn
Apoa2 Clu Gpx3 Mbl1
Apoa4 Col12a1 H2-Q10 Mug1
Apob Col6a3 Habp2 Pla2g7
Apoc3 Cpb2 Hpx Plg
Apod Cpn1 Hrg Pon1
Apoe Cpn2 Ica Postn
Apoh Crp Igh-3 Qsox1
Apom Ecm1 Igh-6 Rbp4
Azgp1 Egfr Il1rap Serpina10
C1qb F10 Itih1 Serpina3n
C3 F12 Itih2 Serpina7
C4b F2 Itih3 Serpinc1






























PBS − day 14
Bleo − day 14














































PBS − day 14
Bleo − day 14

















































-8 -6 -4 -2 0 2 4 6 8 10 12
Abundant in plasma





















Tissue leakage proteinsd3 d7 d14 d21 d28 d56

























247 ELF proteins (significantly 
enriched in lavage versus tissue)
Figure 7. Epithelial lining fluid proteome composition and dynamic changes upon injury and repair.
A Experimental design.
B The histogram depicts MS intensity distributions of the indicated categories.
C The scatter plot shows the relative enrichment of proteins in either tissue or bronchoalveolar lavage fluid proteome. The enrichment score is color-coded as
indicated, and proteins that are highly abundant in plasma are shown as squares.
D The Venn diagram depicts relative proportions of the number of proteins in the indicated categories and experimental conditions.
E, F The box plots depict the distribution of BALF enrichment scores in the indicated gene categories.
G The z-scored MS intensity ratios of the 189 secreted and transmembrane proteins that were significantly regulated (Benjamini–Hochberg FDR < 0.05) were grouped
by correlation using unsupervised hierarchical clustering.
H, I Protein abundance changes over time of the indicated example proteins are shown in the upper panels. The mean log2 MS intensity ratio of bleomycin-treated to
the PBS controls with the standard error of the mean and the P-value of ANOVA are shown. The lower panels depict the protein abundance rank relative to the
complete BALF proteomes. The error bars depict the standard error of the mean.
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2012a, 2014; Rashid et al, 2012; Zanivan et al, 2013). These work-
flows, however, do not distinguish true ECM constituents from
contaminant non-ECM proteins. Some recent studies explored the
possibility of measuring and comparing the protein pools after
differential extraction from tissue (Barallobre-Barreiro et al, 2012;
Decaris et al, 2014). The latter study for instance quantified the
turnover of ECM proteins and compared the insoluble compartment
with the guanidinium hydrochloride-soluble compartment (Decaris
et al, 2014). We further explored the idea of a quantitative compari-
son of sequential protein extracts to characterize ECM proteins
based on their solubility profiles, which we also used to directly
measure the association of secreted proteins with ECM filaments
in vivo. The proteome-wide QDSP data presented here can serve as
confirmation of some of the available affinity measurements for
ECM interactions and as a starting point for new investigations. For
instance, our in vivo QDSP data validated a recent study, which
showed that fibroblast growth factor 2 (Fgf2) strongly bound ECM
proteins in ELISA-based experiments in vitro, while its family
member Fgf1 did not (Martino et al, 2014). In agreement with this
data, we found that Fgf2 was highly insoluble in contrast to Fgf1.
Thus, we believe that QDSP will be useful for future proteomic
investigations of matrisome composition in diverse biological
contexts.
Secreted lung proteins can be present in the interstitial space,
where they are exposed to ECM filaments and might be associated
with them, or in the ELF of the airway lumen, where they are in
solution. We were able to distinguish these two scenarios using
QDSP and the BALF score, which measures relative enrichment in
ELF compared to the tissue compartment. This can be illustrated by
the ECM glycoprotein osteopontin (Spp1), a known marker of
progressive fibrotic disease in IPF patients (Pardo et al, 2005). Spp1
had a soluble QDSP profile (no or weak ECM interaction) but also a
high BALF enrichment score in both PBS controls and bleomycin-
treated animals. Thus, we conclude that surprisingly the pulmonary
Spp1 is mainly derived from epithelial cells and secreted apically
into the airway lumen. Similarly, our global analysis identified
many unexpected proteins as true constituents of ELF and distin-
guished apical from basolateral secretion of epithelium-derived
proteins. Temporal profiling of ELF proteins uncovered a host of
novel candidate proteins with putative functions in early or late
phases of tissue repair, providing a rich resource for functional vali-
dation. Since BAL is a frequent diagnostic procedure for patients
with chronic lung diseases, the highly streamlined nature of our
LC-MS-based proteomic workflow makes the clinical translation of
BALF proteomics an attractive direction for both patient stratifica-
tion and drug target discovery (Blackwell et al, 2014).
Mobilization of tissue-resident progenitor cell and stem cell
populations needed for regeneration of the correct bronchoalveolar
epithelial organization is initiated in the early inflammatory and
fibrogenic phase after injury (up to day 14 in our model), in which
the perivascular niche plays a key role by contributing paracrine
factors (Ding et al, 2011; Lee et al, 2014; Rafii et al, 2015;
Ramasamy et al, 2015). The basement membrane underneath the
epithelial and endothelial cell layers, in particular, is strategically
located to impact on stem cell behavior. Here, we identified an inter-
esting group of extracellular niche proteins, which was upregulated
early after injury (days 3 and 14). It contained a specific set of base-
ment membrane laminins that is normally restricted to embryonic
development (Nguyen & Senior, 2006), and several basement
membrane-associated proteins, including Frem-1 and Slit-3, which
genetically interact in the regulation of lung development (Petrou
et al, 2005; Beck et al, 2013). Moreover, QDSP uncovered increased
solubility of basement membrane proteins, which could be due to
proteolytic processing, as previously shown in lung injury and
repair (Davey et al, 2011), and branching morphogenesis of the
developing lung (Harunaga et al, 2014). Proteolytic processing
might also explain the observed release of basement membrane-
associated Netrins from the insoluble compartment. Netrins inhibit
the outgrowth of ectopic epithelial buds during branching morpho-
genesis in lung development (Liu et al, 2004), and it will be thus
interesting to determine the functional relevance of their release
upon injury. Validation of the newly discovered provisional ECM
proteins Emilin-2 and collagen-XXVIII interestingly suggests that
different mesenchymal cell populations contribute a distinct set of





















Figure 8. Proteomic systems biology view of tissue remodeling upon
injury and repair and protein compartmentalization in the lung.
Tissue repair upon injury involves drastic remodeling of the proteome and the
reactivation of developmental programs. Using state of the art quantitative mass
spectrometry, we quantified more than 8,000 proteins and resolved their
association with cell and tissue compartments as well as their relative
abundance in the inflammation, fibrosis, remodeling, and resolution phases of
tissue repair: (i) The tissue proteome data reflected the dynamics of biological
processes and the transcriptional networks driving them and determined the
relative proportions of various cell lineages along the tissue repair progression
timeline; (ii) in-depth proteomic analysis of BALF and whole tissue discriminated
true components of epithelial lining fluid from tissue leakage proteins and
untangled the temporal regulation of in vivo protein secretion and receptor
ectodomain shedding. This highlighted amultitude of unexpected proteins in ELF
that may have important autocrine and paracrine functions in the different
phases of lung repair and lung homeostasis; and (iii) our solubility profiling
method (QDSP) enabled unbiased analysis of protein interactions in the ECM
in vivo and quantified gain and loss of protein interactions within the ECM upon
bleomycin-induced injury.
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studies in different organs have recently revealed a previously unex-
pected heterogeneity of mesenchymal cell populations during
wound repair (Driskell et al, 2013; Rinkevich et al, 2015). For
instance, the expansion of a-SMA-positive myofibroblasts in injured
lungs is accompanied by the expansion of a set of Pdgfr-b-/Ng2-
positive pericyte-like cells in alveolar regions upon bleomycin-
induced injury (Rock et al, 2011). Emilin-2 is believed to associate
with elastic microfibrils (Doliana et al, 2001), was recently shown
to bind Wnt1 in the extracellular space (Marastoni et al, 2014), and
can directly activate the extrinsic apoptosis pathway (Mongiat et al,
2007). Collagen-XXVIII (Col28a1) is a beaded-filament-forming
collagen of unclear function, which associates with basement
membranes (Veit et al, 2006). It will now be interesting to deter-
mine the specific molecular function of these ECM proteins in the
context of tissue repair processes.
Our quantification of the cell-type-specific protein signatures is in
agreement with lineage tracing studies, demonstrating that damaged
AEC-1 cells are replaced by transdifferentiation of Club/Clara and
AEC-2 cells (Rock et al, 2011). The differentiation of AEC-2 into
AEC-1 can be recapitulated to some extend in vitro, and such studies
have recently identified the transcription factor hepatocyte nuclear
factor 4 alpha (HNF4a) as a putative regulator of this process
(Marconett et al, 2013). We performed bioinformatics analysis of
transcriptional networks and found that HNF4A activity coincided
with recovery of the AEC-1 signature, supporting a function of
HNF4a in AEC-2 to AEC-1 differentiation in vivo. At days 14 and 28,
we observed increased activity of the transcription factor Nrf2
(Nfe2l2), which is activated by reactive oxygen species (ROS) and
known to protect against oxidative damage (Ma, 2013). Nrf2 activity
is essential for successful resolution of fibrosis upon bleomycin-
induced injury (Hecker et al, 2014), and conditional deletion of Nrf2
in airway epithelium causes chronic inflammation upon injury
(Reddy et al, 2011). Furthermore, aged mice and IPF patients, both
of which have a defect in fibrosis resolution, have an imbalance in
Nrf2-dependent redox homeostasis (Hecker et al, 2014). Thus, our
data reemphasize the importance of the Nrf2 module for physiologic
fibrogenesis and wound repair on the level of its target proteins. We
also identified novel putative transcriptional regulators of lung
repair. For instance, the activity of the transcription factor Tbx5 was
in contrast to Nrf2 significantly downregulated in fibrogenesis and
then upregulated in remodeling and resolution. Tbx5 is expressed in
the lung mesenchyme and together with Fgf10 promotes the growth
and branching of the epithelium in the developing lung (Arora et al,
2012). Interestingly, upregulation of Tbx5 was observed in axolotl
limb regeneration (Khan et al, 2002), which supports a potential
role of this factor in lung regeneration.
In conclusion, we provide an extensive resource of methods,
novel molecules, and hypotheses for the regenerative medicine
community and the field of ECM research. Clearly, proteomics is
now capable of tackling highly complex tissue environments,
providing very deep proteome coverage. Integration of the various
datasets enabled us to add an additional dimension of spatial reso-
lution to the pulmonary proteome, which for the first time revealed
epithelial lining fluid composition and association of secreted
proteins with the ECM in vivo. With the time-resolved data, we
were able to predict functions of individual proteins in the early
stages of repair, such as stem cell mobilization, or late stages, such
as the resolution of fibrosis. We also showed that higher-level
systems information can be extracted, such as the activity of tran-
scriptional regulators and signaling pathways along the tissue repair
progression timeline. While we here studied the lung, the physio-
logical process of the onset, progression, and resolution of fibrosis,
and thus the dynamics of protein expression described here, are





Pathogen-free female C57BL/6 mice (10–12 weeks old) were
obtained from Charles River and housed in rooms maintained at
constant temperature and humidity with a 12-h light cycle. Animals
were allowed food and water ad libitum. All animal experiments
were conducted under strict governmental and international guide-
lines. Bleomycin lung injury was induced according to the published
protocols (Konigshoff et al, 2009). Briefly, a single intratracheal
instillation of 50 ll of bleomycin (3 U/kg; Sigma-Aldrich, Taufkir-
chen, Germany), dissolved in sterile saline, was applied using the
MicroSprayer Aerosolizer, Model IA-1C (Penn-Century, Wyndmoor,
PA). Control mice were instilled with 50 ll of saline. After instilla-
tion, mice were kept for 3, 7, 14, 21, 28, and 56 days, respectively.
For analysis, mice were anesthetized with ketamine (135 mg/kg)
and xylazine (7 mg/kg) intraperitoneally, and lung function
measurements and bronchoalveolar lavage were performed as
described below. Finally, lungs were perfused through the heart
with saline to remove remaining blood, and snap-frozen in liquid
nitrogen for proteomic and transcriptomic analyses.
Lung function measurements and bronchoalveolar lavage
To investigate alterations of lung function after bleomycin applica-
tion, we used the forced oscillation technique from FlexiVent
systems (Scireq, Montreal, Canada). We used this system to
measure standard and maximal pressure–volume curves resulting
in clinically relevant parameters such as total lung capacity (TLC),
resistance (R), compliance (C), elastance (E), tissue damping
(resistance) (G), and tissue elasticity (H) of the whole respiratory
system. Anesthetized and relaxed mice were tracheotomized, and
an 18-G cannula placed intratracheally to connect the FlexiVent
system. Lungs were ventilated in volume-driven mode corrected
for mouse whole-body weight, with a positive end-expiratory pres-
sure [PEEP] between three and five and a frequency between 160
and 180 breath/min. After lung function measurements, mice
were exsanguinated, and bronchoalveolar lavage (BAL) was
performed by applying three times 500 ll of PBS with proteinase
inhibitor (Roche, Penzberg, Germany), through the intratracheal
cannula. A return of 1.3 ml approximately was obtained. BAL was
centrifuged, and supernatant was snap-frozen in liquid nitrogen
for further analysis.
Antibodies, immunohistochemistry, and microscopy
For immunofluorescence microscopy, the following primary (i)
and secondary (ii) antibodies (Ab) were used: (i) goat polyclonal
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Ab to collagen 28a1(N-12) (Santa Cruz, sc-104151, 1:100), mouse
monoclonal Ab to smooth muscle actin (clone 1A4) (Sigma-
Aldrich, 06-920, 1:100), rabbit monoclonal Ab to tenascin-C
(Abcam, ab108930, 1:100), rabbit and guinea pig Emelin-2 antisera
(generous gift of Prof. Raimund Wagener (University of Cologne)
and Prof. Paolo Bonaldo (University of Padua) (1:500) and (ii)
donkey anti-goat IgG Alexa Fluor 568, donkey anti-rabbit IgG
Alexa Fluor 488, goat anti-mouse Alexa Fluor 488, goat anti-rabbit
Alexa Fluor 568 (all from Invitrogen, 1:250). Cell nuclei were
stained with DAPI (40,6-diamidino-2-phenylindole, Sigma-Aldrich,
1:2,000). For immunohistochemistry, mouse lungs were perfused
with PBS, fixed in 4% paraformaldehyde (pH 7.0), and embedded
in paraffin. The paraffin sections (2 lm) were deparaffinized and
rehydrated, and the antigen retrieval was accomplished by pres-
sure-cooking (30 s at 125°C and 10 s at 90°C) in citrate buffer
(10 mM, pH 6.0). Inhibition of endogenous peroxidase activity
was achieved by blocking in 3% H2O2 in dH2O for 15 min. The
lung sections were incubated with the primary antibodies over
night at 4°C, washed three times with PBS, and subsequently incu-
bated with the secondary antibodies and DAPI (40,6-diamidino-2-
phenylindole, Sigma-Aldrich, 1:2,000) for 1 h at room temperature.
Finally, the sections were washed three times with PBS and
mounted in fluorescent mounting medium (Dako). Images were
acquired with an LSM 710 (Zeiss) operated in multitrack mode
using the following objectives: Plan-Apochromat 20×/0.8 M27 and
Plan-Apochromat 63×/1.4 M27. The automated microscopy system
was driven by ZEN2009 (Zeiss) software. In order to get an over-
view image of whole lung paraffin sections, a tile image was
acquired (8 × 8 images) with a Plan-Apochromat 20×/0.8 M27
objective. The final images were cropped and adjusted for contrast
and brightness by using the ZEN2012 (Zeiss) software. High-
resolution images were taken with a Plan-Apochromat 63×/
1.4 M27 as a z-stack. Subsequently, the z-stacks were processed as
a maximum intensity projection and adjusted for contrast and
brightness by using the ZEN2009 software.
Sample preparation procedures for proteome analysis—QDSP
Lungs were perfused with PBS through the heart to remove blood.
Then, ~100 mg of total lung tissue (wet weight) was homogenized
in 500 ll PBS (with protease inhibitor cocktail and EDTA) using an
Ultra-turrax homogenizer. After centrifugation, the soluble proteins
were collected and proteins were extracted from the insoluble pellet
in three steps using buffers with increasing stringency [buffer 1:
150 mM NaCl, 50 mM Tris–HCl (pH 7.5), 5% glycerol, 1% IGEPAL
CA-630 (Sigma, #I8896), 1 mM MgCl2, 1× protease inhibitors
(+EDTA), 1% benzonase (Merck, #70746-3), 1× phosphatase inhibi-
tors (Roche, #04906837001); buffer 2: 50 mM Tris–HCl (pH 7.5),
5% glycerol, 150 mM NaCl, fresh protease inhibitor tablet (+EDTA),
1.0% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 1%
benzonase (Merck, #70746-3); and buffer 3: 50 mM Tris–HCl (pH
7.5), 5% glycerol, 500 mM NaCl, protease inhibitor tablet (+EDTA),
1.0% IGEPAL CA-630, 2% sodium deoxycholate, 1% SDS, 1%
benzonase (Merck, #70746-3)]. Insoluble pellets were resuspended
in detergent-containing buffers and incubated for 20 min on ice
(except for buffer 3, which was used at room temperature), followed
by separation of soluble and insoluble material using centrifugation
for 20 min at 16,000 g. The PBS from the tissue homogenate and
the NP40-soluble fraction (buffer 1) was pooled, which together
with the two fractions derived from ionic detergent extraction
(buffers 2 and 3) resulted in a total of three soluble fractions and
one insoluble pellet that were subjected to LC-MS/MS analysis.
Soluble proteins were precipitated with 80% acetone and subjected
to in-solution digestion using a modified published protocol (Kulak
et al, 2014). In brief, protein reduction (10 mM TCEP) and alkyl-
ation (50 mM CAA) were performed at once in 6 M guanidinium
hydrochloride (100 mM Tris–HCl pH 8.5) at 99°C for 15 min. Subse-
quent protein digestion was done in two steps. The first digestion
was done at 37°C for 2 h with LysC (1:50 enzyme to protein ratio)
in 10 mM Tris–HCl (pH 8.5) containing 2 M guanidinium hydro-
chloride (Gdm), 2.7 M urea, and 3% acetonitrile. The second diges-
tion step was done using fresh LysC (1:50 enzyme to protein ratio)
and trypsin (1:20 enzyme to protein ratio) in 600 mM Gdm,
800 mM urea, and 3% acetonitrile at 37°C overnight. For the in-
soluble protein pellet, which is strongly enriched for insoluble ECM
proteins, we optimized the in-solution digestion protocol with
additional steps involving extensive mechanical disintegration and
ultrasonication-aided digestion. The insoluble material was cooked,
reduced, and alkylated in 6 M Gdm for 15 min and then subjected
to 200 strokes in a micro-Dounce device, which reduced the particle
size of the insoluble protein meshwork. We then proceeded with the
two-step digestion protocol described above, which was additionally
aided by 15-min ultrasonication (Bioruptor, Diagenode) in the pres-
ence of the enzymes in both digestion steps.
For tissue proteome time course analysis, a similar sequential
extraction procedure as described above was used. However, in
these experiments, we employed slightly different buffers for extrac-
tion following a commercially available protein extraction kit (Com-
partment Protein Extraction Kit, Millipore). We collected three
protein fractions for LC-MS analysis (two soluble fractions and one
insoluble fraction). The first fraction measured was derived from
proteins soluble in buffer M of the extraction kit [HEPES (pH 7.9),
MgCl2, KCl, EDTA, sucrose, glycerol, sodium deoxycholate, NP-40,
sodium orthovanadate]; the second fraction was derived from
proteins soluble in buffer CS [PIPES (pH 6.8), MgCl2, NaCl, EDTA,
sucrose, SDS, sodium orthovanadate], and finally, we also analyzed
the proteins insoluble in buffer CS as described above for QDSP. To
perform relative quantification of full proteomes in the various
conditions, we summed up the peptide intensities of the three
protein fractions in MaxQuant (Cox & Mann, 2008).
Peptides were purified using stage tips containing a poly-styrene-
divinylbenzene copolymer modified with sulfonic acid groups (SDB-
RPS) material (3M, St. Paul, MN, USA) as previously described
(Kulak et al, 2014). For the QDSP experiments, we separated
peptides in two fractions by sequentially eluting from the SDB-RPS
stage tip material (buffer 1: 150 mM NH4HCO2, 60% acetonitrile,
0.5% FA; buffer 2: 5% ammonia and 80% acetonitrile).
LC-MS/MS analysis
Approximately 2 lg of peptides was separated in a 4-h gradient on a
50-cm long (75 lm inner diameter) column packed in-house with
ReproSil-Pur C18-AQ 1.9-lm resin (Dr. Maisch GmbH). Reverse-
phase chromatography was performed with an EASY-nLC 1000
ultra-high-pressure system (Thermo Fisher Scientific), which was
coupled to a Q Exactive mass spectrometer (Thermo Scientific).
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Peptides were loaded with buffer A (0.1% (v/v) formic acid) and
eluted with a nonlinear 240-min gradient of 5–60% buffer B (0.1%
(v/v) formic acid, 80% (v/v) acetonitrile) at a flow rate of 250 nl/
min. After each gradient, the column was washed with 95% buffer B
and re-equilibrated with buffer A. Column temperature was kept at
50°C by an in-house designed oven with a Peltier element (Thakur
et al, 2011), and operational parameters were monitored in real
time by the SprayQc software (Scheltema & Mann, 2012). MS data
were acquired with a shotgun proteomics method, where in each
cycle a full scan, providing an overview of the full complement of
isotope patterns visible at that particular time point, is followed by
up to ten data-dependent MS/MS scans on the most abundant not
yet sequenced isotopes (top 10 method) (Michalski et al, 2011).
Target value for the full scan MS spectra was 3 × 106 charges in the
300–1,650 m/z range with a maximum injection time of 20 ms and
a resolution of 70,000 at m/z 400. Isolation of precursors was
performed with the quadrupole at a window of 3 Th. Precursors
were fragmented by higher-energy collisional dissociation (HCD)
with normalized collision energy of 25% (the appropriate energy is
calculated using this percentage, and m/z and charge state of the
precursor). MS/MS scans were acquired at a resolution of 17,500 at
m/z 400 with an ion target value of 1 × 105, a maximum injection
time of 120 ms, and fixed first mass of 100 Th. Repeat sequencing
of peptides was minimized by excluding the selected peptide candi-
dates for 40 s.
Computational MS data analysis
MS raw files were analyzed by the MaxQuant software (Cox &
Mann, 2008) (version 1.4.1.12), and peak lists were searched
against the mouse UniProt FASTA database (version May 2013),
and a common contaminants database (247 entries) by the Androm-
eda search engine (Cox et al, 2011). As fixed modification cysteine
carbamidomethylation and as variable modifications, hydroxylation
of proline and methionine oxidation was used. False discovery rate
was set to 0.01 for proteins and peptides (minimum length of seven
amino acids) and was determined by searching a reverse database.
Enzyme specificity was set as C-terminal to arginine and lysine, and
a maximum of two missed cleavages were allowed in the database
search. Peptide identification was performed with an allowed
precursor mass deviation up to 4.5 ppm after time-dependent mass
calibration and an allowed fragment mass deviation of 20 ppm. For
label-free quantification in MaxQuant [MaxLFQ (Cox et al, 2014)],
the minimum ratio count was set to two. For matching between
runs, the retention time alignment window was set to 30 min and
the match time window was 1 min.
RNA-seq
Liquid nitrogen-frozen tissue was homogenized using a micro-
dismembrator (Sartorius, Göttingen, Germany). RNA extraction
from mouse tissue was performed using the Roti Quick kit (Carl
Roth, Karlsruhe, Germany) followed by RNA purification with the
peqGold RNA isolation kit (Peqlab, Erlangen, Germany), according
to the manufacturers’ instructions. For RNA quality assessment,
RNA integrity numbers (RIN) were measured via Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), and
samples with RIN number above 6.5 were used for sequencing.
RNA library preparation was done using the Illumina TruSeq RNA
Sample Prep kit v2 following the manufacturers’ protocol. RNA
sequencing was performed as 100-bp paired-end runs on a
HiSeq2500 (Illumina). Pools of 16 indexed libraries were sequenced
on four lanes. Image analysis and base calling were performed using
Illumina Real Time Analysis. CASAVA 1.8 was used for demultiplexing.
Bioinformatic analysis and statistics
RNA-seq data analysis
The GEM mapper (v 1.7.1) (Marco-Sola et al, 2012) with modified
parameter settings (mismatches = 0.04, min-decoded-strata = 2)
was used for split-read alignment against the mouse genome assem-
bly mm9 (NCBI37) and UCSC knownGene annotation. To quantify
the number of reads mapping to the annotated genes, we used
HTseq-count (v 0.6.0) (Anders et al, 2015). FPKM (fragments per
kilobase of exon per million fragments mapped) values were calcu-
lated using custom scripts.
Data imputation for ratiometric time course analysis
MaxLFQ intensity values were taken from the MaxQuant protein
Groups table, which represent the values after inter-experiment
normalization. From these values, the median intensity from repli-
cates for each of the time points was calculated. Missing values in
these median values were imputed by random selection from a
normal distribution generated at 1.8 standard deviations, subtracted
from the mean, of the total intensity distribution and a width of 0.3
standard deviations. This places the imputed values at the lower
limit of the intensity scale, which represents detection limit of the
used instrumentation. The median values were used to calculate the
ratio between bleomycin-treated and control mice for each replicate
at each acquired time point for those cases where the bleomycin-
treated intensity value was based on at least one valid value. If this
was not the case, data imputation and ratio calculation were done
only where the control had at least 50% valid values (the other
values were marked as missing). The resulting data matrix was
exported for further statistical treatment and visualization.
QDSP—quantitative detergent solubility profiling
The total abundance of proteins in the bleomycin- and PBS-treated
samples were calculated by summing the linear iBAQ values across
the four solubility fractions. The abundance rank plots show the
rank of the mean log2 intensity of the selected protein compared to
the mean log2 intensities of all other proteins. Furthermore, a two-
sample, two-sided t-test is performed comparing the mean log2
intensities between bleomycin- and PBS-treated samples for each
protein.
The solubility profiles across the four fractions are compared
by first normalizing the intensities such that the mean log2 inten-
sities of the bleomycin- and the PBS-treated samples are zero,
respectively. Using the normalized intensities, a two-way ANOVA
with the two-factor treatment (bleomycin/PBS) and solubility frac-
tion (FR1, FR2, FR3, INSOL) and the corresponding interaction
term was performed. Proteins significant in the interaction term
correspond to proteins for which the solubility profile changes
upon bleomycin treatment. Therefore, the corresponding P-value
was used for filtering the significantly changed profiles after FDR
correction.
ª 2015 The Authors Molecular Systems Biology 11: 819 | 2015
Herbert B Schiller et al Proteomics of tissue injury and repair Molecular Systems Biology
15
Tissue proteome time course analysis
For each protein, the ratio between the protein intensity in bleo-
mycin-treated samples, and the mean intensity of the protein in the
PBS-treated samples was calculated and log2-transformed. To iden-
tify proteins whose expression changes over time, one-way ANOVA
was applied to these log2 ratios. In addition, a linear regression
analysis was performed with the independent variable compliance
ratio of the corresponding sample and the dependent variable protein
ratio. In addition, the Pearson correlation coefficient and the correla-
tion P-value were calculated for each protein.
BALF proteome analysis
Similar as for the tissue proteome, the expression ratio of bleomy-
cin- and PBS-treated samples was calculated for further analysis,
where the PBS expression value was averaged across all replicates
and time points. To identify proteins, whose expression changes
upon treatment with bleomycin, a two-sample, two-sided t-test was
performed for data obtained at day 14. To identify proteins, whose
expression ratio changes over time, a one-way ANOVA was
performed on the expression ratios.
The t-test-based BALF enrichment score was calculated as in
formula one in the paper Tusher et al (2001). The statistic is based
on the ratio of change in gene expression to standard deviation in
the data for that gene. The “gene-specific scatter” s(i) is the standard
deviation of the replicates.
FDR correction
All P-values were corrected for multiple hypothesis testing using the
Benjamini–Hochberg method (Benjamini & Hochberg, 1995), and
only proteins significant at the specified FDR were reported.
P-values are marked by an asterisk in the plots, if they are smaller
than 0.05. All profile plots show the mean intensity or ratio, respec-
tively; the error bars correspond to the standard error of the mean.
All scripts performing the statistical analysis and generating the
plots were implemented in MATLAB (Mathworks).
Ingenuity pathway analysis
To predict the activity of downstream biological processes and
upstream transcriptional regulators and growth factors based on the
observed protein abundance ratios, we used the Ingenuity Pathway
Analysis platform (IPA, QIAGEN Redwood City, www.qiagen.
com/ingenuity). We used a suite of algorithms and tools embedded
in IPA for inferring and scoring regulator networks upstream of
gene expression data based on a large-scale causal network derived
from the Ingenuity Knowledge Base. The analytics tool “Upstream
Regulator Analysis” (Kramer et al, 2014) was used to compare the
known effect (transcriptional activation or repression) of a tran-
scriptional regulator on its target genes to the observed changes in
protein abundance to assign an activation Z-score. Since it is a priori
unknown which causal edges in the master network are applicable
to the experimental context, the “Upstream Regulator Analysis” tool
uses a statistical approach to determine and score those regulators
whose network connections to dataset genes as well as associated
regulation directions are unlikely to occur in a random model
(Kramer et al, 2014). In particular, the tool defines an overlap
P-value measuring enrichment of network-regulated genes in the
proteomic dataset, as well as an activation Z-score which can be
used to find likely regulating molecules based on a statistically
significant pattern match of up- and downregulation, and also to
predict the activation state (either activated or inhibited) of a puta-
tive regulator. In our analysis, we restricted the “Upstream Regula-
tor Analysis” to the categories “transcriptional regulator” and
“growth factor” in the IPA filter settings. We considered proteins
with an overlap P-value of > 3 (log10) that had an activation Z-score
> 2.5 as activated and those with an activation Z-score <2.5 as
inhibited. Using the “Downstream Effects Analysis” (Kramer et al,
2014) embedded in IPA, we aimed at identifying those biological
processes and functions that are likely to be causally affected by
up- and downregulated proteins in the proteomic dataset. The
approach is very similar to that of “Upstream Regulator Analysis,”
except that the direction of edges connecting the dataset genes
with the predicted entity (here, the biological process) is reversed.
We confined our analysis to “Molecular and Cellular Functions &
Physiological System Development and Function” and accepted an
overlap P-value of > 3 (log10). Biological processes with an activa-
tion Z-score > 2 were considered as activated and those with an
activation Z-score <2 as inhibited.
Software packages for statistics and data visualization
For basic data handling, normalization, statistics (if not stated other-
wise), and annotation enrichment analysis, we used the freely avail-
able open-source bioinformatics platform Perseus (http://141.61.
102.17/perseus_doku/doku.php?id=start). Perseus was used to
visualize data from principal component analysis, non-supervised
hierarchical clustering, and scatter plots. Furthermore, the 1D and
2D annotation algorithms and Fisher’s exact tests implemented in
Perseus (Cox & Mann, 2012) were used for annotation enrichment
analysis. Bar graphs and box plots were generated in the GraphPad
PRISM software (http://www.graphpad.com/scientific-software/
prism/).
Data access via the MaxQB database and proteomics raw
data repository
Protein centric data from proteomic experiments are available via
the MaxQB database (Schaab et al, 2012) via the following URL:
http://maxqb.biochem.mpg.de/mxdb/project/show/P013
The site offers detailed information on protein identification data
as well as data visualization plots, which can be accessed via the
protein groups tab.
The mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium (Vizcaino et al, 2014) via the
PRIDE partner repository with the dataset identifier PXD001765.
Expanded View for this article is available online:
http://msb.embopress.org
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